2007
DOI: 10.1016/j.placenta.2006.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Significance of Donor Anuria Differs between Monoamniotic and Diamniotic Twin–Twin Transfusion Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 10 publications
0
0
1
1
Order By: Relevance
“…In 318 placentas (94%) one or more A-V anastomoses were present. The only difference in type and number of anastomoses between MA and MC placentas was the almost ubiquitous presence of A-A anastomoses in MA placentas; it was only absent in 1 of 43 monoamniotic placentas 29. This is in contrast with the observation of Bajoria, who reported that MA placentas have significantly greater numbers of both superficial and deep anastomoses than do uncomplicated MC diamniotic pregnancies 30.…”
Section: Vascular Anatomy Of Monochorionic Placentas and Correlation contrasting
confidence: 57%
“…In 318 placentas (94%) one or more A-V anastomoses were present. The only difference in type and number of anastomoses between MA and MC placentas was the almost ubiquitous presence of A-A anastomoses in MA placentas; it was only absent in 1 of 43 monoamniotic placentas 29. This is in contrast with the observation of Bajoria, who reported that MA placentas have significantly greater numbers of both superficial and deep anastomoses than do uncomplicated MC diamniotic pregnancies 30.…”
Section: Vascular Anatomy Of Monochorionic Placentas and Correlation contrasting
confidence: 57%
“…В то же время в трех крупных рандомизированных исследованиях продемонстрировано, что прогестерон эффекти-вен как средство профилактики преждевремен-ных родов при одноплодной беременности, от-носящейся к группе высокого риска. В последние годы раскрыты основные (прежде всего иммун-ные) механизмы осуществления гестагенами их защитной функции в отношении плода [5,45,46,47,48]. У пациенток, относящихся к группе вы-сокого риска (наличие преждевременных родов в анамнезе или укорочение шейки матки), приме-нение прогестерона в дородовом периоде приво-дило к снижению частоты досрочного заверше-ния беременности на 35% [47,48,49,50,51,52].…”
unclassified